Búsqueda | Biblioteca Virtual en Salud

1.

Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.

Guan, Weihua; Cao, Jing; Steffen, Brian T; Post, Wendy S; Stein, James H; Tattersall, Mathew C; Kaufman, Joel D; McConnell, Joseph P; Hoefner, Daniel M; Warnick, Russell; Tsai, Michael Y.

Arterioscler Thromb Vasc Biol ; 35(4): 996-1001, 2015 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-25810300

2.

New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis.

Tsai, Michael Y; Steffen, Brian T; Guan, Weihua; McClelland, Robyn L; Warnick, Russell; McConnell, Joseph; Hoefner, Daniel M; Remaley, Alan T.

Arterioscler Thromb Vasc Biol ; 34(1): 196-201, 2014 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-24233487

3.

Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices.

Cole, Thomas G; Contois, John H; Csako, Gyorgy; McConnell, Joseph P; Remaley, Alan T; Devaraj, Sridevi; Hoefner, Daniel M; Mallory, Tonya; Sethi, Amar A; Warnick, G Russell.

Clin Chem ; 59(5): 752-70, 2013 May.

Artículo en Inglés | MEDLINE | ID: mdl-23386699

4.

Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices.

Contois, John H; McConnell, Joseph P; Sethi, Amar A; Csako, Gyorgy; Devaraj, Sridevi; Hoefner, Daniel M; Warnick, G Russell.

Clin Chem ; 55(3): 407-19, 2009 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-19168552

5.

In reply.

Cole, Thomas G; Contois, John H; Csako, Gyorgy; McConnell, Joseph P; Remaley, Alan T; Devaraj, Sridevi; Hoefner, Daniel M; Mallory, Tonya; Sethi, Amar A; Warnick, G Russell.

Clin Chem ; 59(8): 1277-8, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-24049794

6.

Lipoprotein-associated phospholipase A2.

McConnell, Joseph P; Hoefner, Daniel M.

Clin Lab Med ; 26(3): 679-97, vii, 2006 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-16938590

7.

Serum tumor markers: part II--practical considerations and limitations of testing.

Hoefner, Daniel M.

MLO Med Lab Obs ; 38(2): 10-1, 14-6; quiz 18-9, 2006 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-16583620

8.

Serum tumor markers. Part I: Clinical utility.

Hoefner, Daniel M.

MLO Med Lab Obs ; 37(12): 20, 22-4, 2005 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-16435773

9.

Hypertriglyceridaemia unresponsive to multiple treatments.

Backes, James M; Dayspring, Thomas D; Hoefner, Daniel M; Moriarty, Patrick M.

BMJ Case Rep ; 20152015 Oct 14.

Artículo en Inglés | MEDLINE | ID: mdl-26468219

10.

Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population.

Wolin, Elliott; White, Justin; Pottala, James V; Sasinowski, Maciek; Dall, Tara; Dayspring, Thomas D; McConnell, Joseph P; Hoefner, Daniel M; Varvel, Stephen A; Thiselton, Dawn L; Warnick, G Russell; Harris, William S.

J Clin Lipidol ; 9(6): 817-823, 2015.

Artículo en Inglés | MEDLINE | ID: mdl-26687703

11.

Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis.

Guadagno, Philip A; Summers Bellin, Erin G; Harris, William S; Dayspring, Thomas D; Hoefner, Daniel M; Thiselton, Dawn L; Stanovick, Brant; Warnick, G Russell; McConnell, Joseph P.

Clin Chim Acta ; 439: 219-24, 2015 Jan 15.

Artículo en Inglés | MEDLINE | ID: mdl-25451955

12.

Lipoprotein(a) mass: a massively misunderstood metric.

McConnell, Joseph P; Guadagno, Philip A; Dayspring, Thomas D; Hoefner, Daniel M; Thiselton, Dawn L; Warnick, G Russell; Harris, William S.

J Clin Lipidol ; 8(6): 550-553, 2014.

Artículo en Inglés | MEDLINE | ID: mdl-25499936

13.

The cholesterol controversy continues.

Hoefner, Daniel M.

MLO Med Lab Obs ; 40(4): 24, 26, 28 passim, 2008 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-18488541

14.

Myocardial tissue remodeling in adolescent obesity.

Shah, Ravi V; Abbasi, Siddique A; Neilan, Tomas G; Hulten, Edward; Coelho-Filho, Otavio; Hoppin, Alison; Levitsky, Lynne; de Ferranti, Sarah; Rhodes, Erinn T; Traum, Avram; Goodman, Elizabeth; Feng, Henry; Heydari, Bobak; Harris, William S; Hoefner, Daniel M; McConnell, Joseph P; Seethamraju, Ravi; Rickers, Carsten; Kwong, Raymond Y; Jerosch-Herold, Michael.

J Am Heart Assoc ; 2(4): e000279, 2013 Aug 20.

Artículo en Inglés | MEDLINE | ID: mdl-23963758

15.

New HDL-cholesterol reagent formulation reduces interference from samples with abnormal proteins.

Hoefner, Daniel M.

Clin Chim Acta ; 374(1-2): 142-4, 2006 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-16701600

16.

The ruthless malady: metabolic syndrome.

Hoefner, Daniel M.

MLO Med Lab Obs ; 35(10): 12-6, 20, 22-3; quiz 24-5, 2003 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-14571847

17.

Lot-to-lot inconsistency of anticardiolipin reagents.

Hoefner, Daniel M; Yeo, Kiang-Teck J.

Clin Chem ; 48(9): 1625-6; author reply 1626, 2002 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-12194956

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.

New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis.

Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices.

Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices.

In reply.

Lipoprotein-associated phospholipase A2.

Serum tumor markers: part II--practical considerations and limitations of testing.

Serum tumor markers. Part I: Clinical utility.

Hypertriglyceridaemia unresponsive to multiple treatments.

Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population.

Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis.

Lipoprotein(a) mass: a massively misunderstood metric.

The cholesterol controversy continues.

Myocardial tissue remodeling in adolescent obesity.

New HDL-cholesterol reagent formulation reduces interference from samples with abnormal proteins.

The ruthless malady: metabolic syndrome.

Lot-to-lot inconsistency of anticardiolipin reagents.